IRON-HFpEF - Iron substitution with ferric carboxymaltose as treatment strategy for heart failure patients with preserved ejection fraction: A prospective, double-blind placebo-controlled trial
Project funded by own resources
Project title IRON-HFpEF - Iron substitution with ferric carboxymaltose as treatment strategy for heart failure patients with preserved ejection fraction: A prospective, double-blind placebo-controlled trial
Principal Investigator(s) Dieterle, Thomas
Project Members Bösing, Maria
Thesenvitz, Elke
Brighenti-Zogg, Stefanie
Mundwiler, Jonas
Organisation / Research unit Faculty of Medicine,
Departement Klinische Forschung,
Bereich Medizinische Fächer (Klinik),
Bereich Medizinische Fächer (Klinik) / Allgemeine innere Medizin Liestal (Leuppi)
Project start 27.05.2019
Probable end 30.06.2021
Status Active
Abstract

IRON-HFpEF is a prospective, double-blind, placebo-controlled trial that investigates the function and structural effects of iron substitution with ferric carboxymaltose on the cardiovascular system in heart failure patients with preserved ejection fraction.

Financed by Other funds
   

MCSS v5.8 PRO. 0.618 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
10/08/2020